Skip to content

APOTHEEK PHARMAVIE

Active
Private limited companyfounded 1987active for 39 yearsHoogstraat 5, 9960 Assenede, BelgiumKBO/BCE: BE 0432.179.441
Summary

APOTHEEK PHARMAVIE has been active since 1987 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €46,977 and a net result of -€28,835. Equity has been shrinking by about 13% per year since 2018. Its solvency ranks better than 15% of 12,781 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 1.1% (low).

Overview

Official details

Source: KBO
Status
Active since 01-10-1987 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730
Joint committee
313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2025
Establishment unit
2.032.618.667 9960 Assenede, since 19-11-1987
Financial year end
31 December
Peppol
Reachable since 23-12-2025

Board and ownership

Board
Shareholders

Financial position

65 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
1.1%
Annual accounts 2025
Gross margin
€274,618
▲ 6.7%
Turnover
≈ €1.0m
estimated
Loss
€28,835
Equity
€46,977
▼ 38.0%
Total assets
€2.2m
▲ 187%
Employees on 31-12-2025
5
▲ 66.7%
Score breakdownraises riskEquity €46,977 (2.2% of total assets)1 change of registered office in 24 monthsSector: Retail trade (NACE 47)lowers riskSize: 3.2 FTE, total assets €2.2mShow the evidence

Checked score

Score 2025
65 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially stronger than 26% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Weak
Solvency 27-8
equity 2.2% of total assets
Liquidity 40+12
short-term debt 45.1% · cash 9.5%
Profitability 44-13
return on assets -1.3%
Bankruptcy probability within 12 months
1.1% Low
0%0.5%1.5%4%10%≥ 25%

About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,281 companies, NACE 47, micro)
Last 24 months 12-2024: 0.5% 01-2025: 0.5%● unchanged vs 12-2024 02-2025: 0.5%● unchanged vs 01-2025 03-2025: 0.5%● unchanged vs 02-2025 04-2025: 0.5%● unchanged vs 03-2025 05-2025: 0.5%● unchanged vs 04-2025 06-2025: 0.4%▼ -0.1 percentage points vs 05-2025lowest value 07-2025: 0.4%● unchanged vs 06-2025lowest value 08-2025: 0.4%● unchanged vs 07-2025lowest value 09-2025: 0.4%● unchanged vs 08-2025lowest value 10-2025: 0.4%● unchanged vs 09-2025lowest value 11-2025: 0.4%● unchanged vs 10-2025lowest value 12-2025: 0.9%▲ +0.5 percentage points vs 11-2025 01-2026: 0.9%● unchanged vs 12-2025 02-2026: 0.9%● unchanged vs 01-2026 03-2026: 0.9%● unchanged vs 02-2026 04-2026: 0.9%● unchanged vs 03-2026 05-2026: 1.1%▲ +0.2 percentage points vs 04-2026 06-2026: 1.2%▲ +0.1 percentage points vs 05-2026highest value 07-2026: 1.1%▼ -0.1 percentage points vs 06-2026 08-2026: 1.1%● unchanged vs 07-2026 09-2026: 1.1%● unchanged vs 08-2026 10-2026: 1.1%● unchanged vs 09-2026 11-2026: 1.1%● unchanged vs 10-2026
Credit of up to €3,000 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.96 (1.32 in 2024), below 1. Short-term debt is 45.1% and cash 9.5% of total assets. 97.8% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 20% of them on solvency, 38% on liquidity, 33% on profitability and 13% on growth.

The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Equity €46,977 (2.2% of total assets)
NBB · annual accounts
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Size: 3.2 FTE, total assets €2.2m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 15% of 12781 sector peers (2025).
NBB · sector comparison
Position among 12781 sector peers
Solvency
better than 15%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-06-2026, 45 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
45 days early
2024
73 days early
2023
56 days early
2022
66 days early
2021
62 days early
2020
24 days early
2019
32 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 51 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 May (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
04-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: From profit to loss in 2025after a profit of €57,339 in 2024 -€28,835 View
  • Caution: Lower net result than 88% of companies in retail tradesector median €27,551 · 12,770 companies -€28,835 View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View

Recent changes

  1. · Gazette deed Registered office moved within AssenedeNew seat: Hoogstraat 5, 9960 Assenede · Previous seat: Markt 15, 9960 Assenede
  2. · Gazette deed Amendment of the articles · Legal-form change · Resignations & appointmentsAppointment: GROUP DE SURGELOOSE (director) · Permanent representative: DE SURGELOOSE Frank · Resignation: DE SURGELOOSE Frank (director)
  3. · Gazette deed Incorporation
All 16 events

Comparable companies

These companies have the same main activity as APOTHEEK PHARMAVIE: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.7m and €2.6m, founded between 1982 and 1991.

CompanyTotal assetsGross margin
APOTHEEK PHARMAVIE Assenede€2.2m€0.3m
APOTHEEK VAN CLEEMPUT Maldegem€2.6m€0.3m
VIDAFAR Deinze€2.4m€0.3m
FARMAGORA Ternat€1.8m€0.3m
APOTHEEK GODERIS & VINCENT Staden€2.0m€0.3m
PHARMACIE DAVOINE Vorst€2.0m€0.4m
APOTHEEK VANDERSTRAETEN Gent€1.7m€0.3m
Full comparison

Key facts about APOTHEEK PHARMAVIE

What is the company number of APOTHEEK PHARMAVIE?
The company number of APOTHEEK PHARMAVIE is 0432.179.441. The VAT number is the same number with BE in front: BE 0432.179.441.
Where is APOTHEEK PHARMAVIE based?
The registered office is at Hoogstraat 5, 9960 Assenede.Company details
What does APOTHEEK PHARMAVIE do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK PHARMAVIE?
The legal form of APOTHEEK PHARMAVIE is Private limited company (BV).
When was APOTHEEK PHARMAVIE founded?
APOTHEEK PHARMAVIE was founded on 01-10-1987.
Is APOTHEEK PHARMAVIE still active?
Yes, APOTHEEK PHARMAVIE is an active enterprise in the KBO register.
How many employees does APOTHEEK PHARMAVIE have?
APOTHEEK PHARMAVIE had an average of 3.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does APOTHEEK PHARMAVIE fall under?
In its 2025 annual accounts, APOTHEEK PHARMAVIE states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
What is the turnover of APOTHEEK PHARMAVIE?
The turnover in financial year 2025 is ≈ €1.0m. This figure is estimated from the gross margin of €274,618 and 47 comparable companies (NACE 477). It probably lies between €780,000 and €1.6m.
Is APOTHEEK PHARMAVIE profitable?
In financial year 2025, APOTHEEK PHARMAVIE made a loss of €28,835.
Where can I find the annual accounts of APOTHEEK PHARMAVIE?
APOTHEEK PHARMAVIE filed 38 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK PHARMAVIE due?
APOTHEEK PHARMAVIE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.